We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02872025
Brief Title: Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS)

First Submitted : August 10, 2016
First Submitted that Met QC Criteria : August 15, 2016
First Posted : August 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 21, 2022
Last Update Posted : October 25, 2022